Utilization of intravenous proton pump inhibitors in non-critically III patients and the impact of pharmacist-led interventions in a private tertiary hospital

Background: Proton Pump Inhibitors (PPIs) have become the mainstay of antisecretory therapy for many acid-related disorders because of their well-documented effects in relieving symptoms and healing mucosal lesions. (Savarino, et al., 2017; Alhazzani et al, 2013) However, they are often overused and...

Полное описание